The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 21, 2014

Filed:

May. 06, 2011
Applicants:

Raymond J. Deshaies, Claremont, CA (US);

Tsui-fen Chou, Pasadena, CA (US);

Frank J. Schoenen, Lawrence, KS (US);

Kelin LI, Lawrence, KS (US);

Kevin J. Frankowski, Lawrence, KS (US);

Jeffrey Aube, Lawrence, KS (US);

Samuel W. Gerritz, Guilford, CT (US);

Han-jie Zhou, Foster City, CA (US);

Inventors:

Raymond J. Deshaies, Claremont, CA (US);

Tsui-Fen Chou, Pasadena, CA (US);

Frank J. Schoenen, Lawrence, KS (US);

Kelin Li, Lawrence, KS (US);

Kevin J. Frankowski, Lawrence, KS (US);

Jeffrey Aube, Lawrence, KS (US);

Samuel W. Gerritz, Guilford, CT (US);

Han-Jie Zhou, Foster City, CA (US);

Assignees:

California Institute of Technology, Pasadena, CA (US);

The University of Kansas, Lawrence, KS (US);

Cleave Biosciences, Inc., Burlingame, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/54 (2006.01); A61K 31/535 (2006.01); A61K 31/538 (2006.01); A61K 31/517 (2006.01); A61K 31/4184 (2006.01); C12Q 1/42 (2006.01); A61K 31/53 (2006.01); C12Q 1/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); G01N 2500/02 (2013.01); A61K 31/538 (2013.01); A61K 31/4184 (2013.01); C12Q 1/42 (2013.01); A61K 31/53 (2013.01); C12Q 1/485 (2013.01);
Abstract

Compounds of Formulas I-XLIII are identified as direct inhibitors of p97 ATPase or of the degradation of a p97-dependent ubiquitin-proteasome system (UPS) substrate. Methods and compositions are disclosed for inhibiting p97 ATPase and the degradation of a p97-dependent UPS substrate, and for identifying inhibitors thereof.


Find Patent Forward Citations

Loading…